text.skipToContent text.skipToNavigation
Need help? Please contact us

Scaling Up for Clinical Use - CAR-T Cell Expansion

We have more articles to read for you

Article overview

CAR-T therapy overview

CAR-T therapy is a new cutting edge treatment involving modification of human T cells, but also has some challenges to overcome. Learn more about it in a brief overview of this therapy.

The basics of clinical trials

Learn more about the clinical trials: What are they exactly? What types of trials are there? How many phases are there? What happens in each phase?

Summary of strengths

Learn more about CAR-NK cells and automated production for immunotherapy.

Interested in our webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Knowledge Center

Need technical data?

Browse our Cell and Transfection, Citation, FAQ and Culture Media Technical Databases.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

References

Morita D, Nishio N, Saito S, Tanaka M, Kawashima N, Okuno Y, Suzuki S, Matsuda K, Maeda Y, Wilson MH, Dotti G, Rooney CM, Takahashi Y, Nakazawa Y. Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells. Mol Ther Methods Clin Dev. 2018 Mar 16; 8: 131–140